US Patent Issued to OSLO UNIVERSITETSSYKEHUS HF on April 21 for "Recombinant CCN domain proteins and fusion proteins" (Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,602, issued on April 21, was assigned to OSLO UNIVERSITETSSYKEHUS HF (Nydalen, Norway). "Recombinant CCN domain proteins and fusion protei... Read More

US Patent Issued to Seattle Children's Hospital on April 21 for "IL-13 receptor alpha 2 targeted, zetakine directed T cell immunotherapy" (Washington Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,603, issued on April 21, was assigned to Seattle Children's Hospital (Seattle). "IL-13 receptor alpha 2 targeted, zetakine directed T cell... Read More

US Patent Issued to Regents of the University of Minnesota on April 21 for "Therapeutic compounds and methods" (Minnesota Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,604, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis). "Therapeutic compounds and methods" was inv... Read More

US Patent Issued to AKSTON BIOSCIENCES on April 21 for "Ultra-long acting insulin-Fc fusion proteins and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,605, issued on April 21, was assigned to AKSTON BIOSCIENCES Corp. (Beverly, Mass.). "Ultra-long acting insulin-Fc fusion proteins and meth... Read More

US Patent Issued to RESTORE VISION on April 21 for "Nucleic acid construct that encodes chimeric rhodopsin" (Japanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,606, issued on April 21, was assigned to RESTORE VISION INC. (Tokyo). "Nucleic acid construct that encodes chimeric rhodopsin" was invente... Read More

US Patent Issued to Immunocore on April 21 for "T cell receptors" (British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,607, issued on April 21, was assigned to Immunocore Ltd. (Abingdon, Great Britain). "T cell receptors" was invented by Conor Hayes (Abingd... Read More

US Patent Issued to Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz on April 21 for "Modified NK-92 cells, and therapeutic and diagnostic uses thereof" (German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,608, issued on April 21, was assigned to Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz (Mainz, Germany). "Modified NK-92 ce... Read More

US Patent Issued to CHIESI FARMACEUTICI on April 21 for "Polypeptides having improved properties" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,609, issued on April 21, was assigned to CHIESI FARMACEUTICI S.p.A. (Parma, Italy). "Polypeptides having improved properties" was invented... Read More

US Patent Issued to Azitra on April 21 for "Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes" (Connecticut, Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,610, issued on April 21, was assigned to Azitra Inc (Branford, Conn.). "Compositions and methods for treatment of Netherton Syndrome with ... Read More

US Patent Issued to The United States of America as represented by the Secretary Department of Health & Human Services on April 21 for "Antibodies which specifically bind to dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1) and methods of use thereof to detect a DENV4 infection" (Puerto Rico, Colorado Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,611, issued on April 21, was assigned to The United States of America as represented by the Secretary Department of Health & Human Services... Read More

• ««
• «
• 13170
• 13171
• 13172
• 13173
• 13174
• 13175
• 13176
• 13177
• 13178
• 13179
• »
• »»